NEW YORK, June 7, 2016 /PRNewswire/ --
http://www.FinancialBuzz.com: Wearable devices is an enormous
market with constant advancement in technologies. A market research
by IDTechEx Research shows how the wearable devices market was
segmented in 2015. The largest segment, Advanced Infotainment,
which mostly includes all the smart watches from Apple, and Samsung
that sync with smartphones and tablets. The second largest segment
is the one with long term prospects and technological potential,
the Health, Medical, Fitness and Wellness segment. Biotricity Inc.
(OTC: BTCY), Koninklijke Philips NV (NYSE: PHG), Medtronic PLC
(NYSE: MDT), Fitbit Inc. (NYSE: FIT), Apple Inc. (NASDAQ: AAPL)
A recent report by Frost & Sullivan, a consulting firm which
provides market research and analysis, claims that the global
healthcare wearable devices market earned revenues of $5.1 billion in 2015 and estimates revenues to
reach $18.9 billion in 2020. This
suggests a growth of 270% in 5 years. The report further elaborates
that new technology will provide commercialized solutions, drive up
demand, and wearables in the medical segment dedicated to chronic
disease monitoring and other clinical purposes can transform care
provision models.
While most companies try to appeal to various segments of the
wearable devices markets, some made transforming healthcare
industry to help physicians better monitor patients their goal. A
little known company Biotricity Inc. (OTCQB: BTCY) is focusing on
biometric monitoring solutions for medical, healthcare and consumer
use. The company has two devices that will launch into the market
this year, Bioflux and Biolife.
Bioflux includes an ECG (heart-rhythm) monitoring device, software
and access to a monitoring lab. The software component is already
FDA approved and a standard for ECG monitoring in hospitals and
cardiac clinics. Bioflux is by all means, a medical wearable
device, and is only available with a prescription. It performs
remote MCT diagnostic monitoring for up to 30 consecutive days and
is a solution that enables physicians to diagnose Cardiovascular
Disease (CVD) or Coronary Heart Disease (CHD).
Biolife is a much more easily accessible device. It is designed to
provide health and lifestyle solutions by monitoring ECG,
respiration rate, calories, temperature, physical activity and
more. The product is currently in development stages and will be
ready to hit the market in the near future. Essentially, Biolife is
a medical device designed to facilitate disease management, example
Cardiovascular monitoring.
Biotricity recently announced the company has appointed
Thomas Nelson and J. Bernard Rice to its newly formed Board of
Advisors (BOA). "As we continue to look to the future of
Biotricity, it's extremely important that the company receives
timely insight and knowledge from industry experts who know and
understand our business and what benefits both consumers and the
medical community…", stated Waqaas Al-Siddiq, founder, president
and CEO of Biotricity.
Companies like Koninklijke Philips NV (NYSE: PHG) and Medtronic PLC
(NYSE: MDT) have been the medical devices business for decades, and
it was only a matter of time until they capitalize on wearable
devices. Back in 2014 Medtronic acquired Corventis, which made
noninvasive cardiac sensors. Medtronic then announced its first
medical wearable device, the Seeq Mobile Cardiac Telemetry (MCT)
System.
Then there is Fitbit (NASDAQ: FIT). The company's CEO,
James Park, focused heavily on the
potential in the medical device segment after the recent earnings
report. "We are learning that lack of consumer engagement is a
critical missing element in many broad healthcare efforts such as
population health and disease management," he said, "…Since our
devices and services are already engaging, Fitbit has incredible
opportunity to serve as the consumer healthcare engagement
engine."
Playing a wider role in medical wearable devices is becoming
a main priority. Despite the impressive growth expectations for
this segment, there are some challenges companies will have to deal
with in the near term, like high costs and lack of insurance
policies. These challenges however are expected to be resolve
overtime and are normal to new technologies in the medical
field.
For "The Latest Buzz in Financial News", Please Visit:
http://www.FinancialBuzz.com
About FinancialBuzz.com
FinancialBuzz.com, a leading financial news informational web
portal designed to provide the latest trends in Market News,
Investing News, Personal Finance, Politics, Entertainment, in-depth
broadcasts on Stock News, Market Analysis and Company Interviews. A
pioneer in the financially driven digital space, video production
and integration of social media, FinancialBuzz.com creates 100%
unique original content.
FinancialBuzz.com also provides financial news PR branding,
marketing and advertising for third parties for disseminating news
and original content through our unique media platform that
includes Newswire Delivery, Digital Advertising, Social Media
Relations, Video Production, Broadcasting, and Financial
Publications.
Please Note: FinancialBuzz.com is not a financial advisory or
advisor, investment advisor or broker-dealer and do not undertake
any activities that would require such registration. The
information provided on http://www.FinancialBuzz.com (the "Site")
is either original financial news or paid advertisements provided
[exclusively] by our affiliates (sponsored content),
FinancialBuzz.com, a financial news media and marketing firm enters
into service agreements with the companies which are the subject to
the articles posted on the Site for advertising such companies.
Financialbuzz.com has signed a three month financial news pr
services agreement for fifteen thousand
dollars directly from biotricity inc. We are not an
independent news media provider and therefore do not represent or
warrant that the information posted on the Site is accurate,
unbiased or complete. FinancialBuzz.com receives fees for producing
and presenting the high quality and sophisticated content on this
site along with other financial news pr media services. Our
fees may be either a flat cash sum or negotiated number of
securities of the companies featured on this site, or a combination
thereof. The securities are commonly paid in segments, of
which a portion is received upon engagement and the balance is paid
on or near the conclusion of the engagement. FinancialBuzz.com
agreed to a three month financial news pr services agreement for
fifteen thousand restricted shares directly from the company and
additional same amount at the end of the term. We do not undertake
to update any of the information on the Site or continue to post
information about any companies the information contained herein is
not intended to be used as the basis for investment decisions and
should not be considered as investment advice or a recommendation.
The information contained herein is not an offer or solicitation to
buy, hold or sell any security. FinancialBuzz.com, members
and affiliates are not responsible for any gains or losses that
result from the opinions expressed on the Site, company profiles,
quotations or in other materials or presentations that it publishes
electronically or in print. Investors accept full
responsibility for any and all of their investment decisions based
on their own independent research and evaluation of their own
investment goals, risk tolerance, and financial condition.
FinancialBuzz.com. By accessing this website and any pages thereof,
you agree to be bound by the Terms of Use and Privacy Policy, as
may be amended from time to time. None of the content issued by
FinancialBuzz.com constitutes a recommendation for any investor to
purchase, hold or sell any particular security, pursue a particular
investment strategy or that any security is suitable for any
investor. This publication is provided by FinancialBuzz.com. Each
investor is solely responsible for determining whether a particular
security or investment strategy is suitable based on their
objectives, other securities holdings, financial situation needs,
and tax status. You agree to consult with your investment advisor,
tax and legal consultant before making any investment decisions. We
make no representations as to the completeness, accuracy or
timeless of the material provided. All materials are subject to
change without notice. Information is obtained from sources
believed to be reliable, but its accuracy and completeness are not
guaranteed. For our full disclaimer, disclosure and Terms of Use.
Please visit: http://www.financialbuzz.com
Media Contact:
Danny A.
info@financialbuzz.com
+1-877-601-1879
SOURCE FinancialBuzz.com.